Nipro Corp

5FA

Company Profile

  • Business description

    Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

  • Contact

    3-9-3 Honjo-Nishi Kita-ku
    Osaka531-8510
    JPN

    T: +81 663722331

    http://www.nipro.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 March 2025

    Employees

    39,233

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,148.9093.601.16%
CAC 408,111.8959.58-0.73%
DAX 4022,998.21289.85-1.24%
Dow JONES (US)42,161.81197.180.47%
FTSE 1008,703.932.73-0.03%
HKSE24,219.95551.19-2.23%
NASDAQ17,865.56114.770.65%
Nikkei 22537,751.8893.54-0.25%
NZX 50 Index12,054.728.790.07%
S&P 5005,700.9725.680.45%
S&P/ASX 2007,918.9090.601.16%
SSE Composite Index3,408.9517.48-0.51%

Market Movers